BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 27084844)

  • 1. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93.
    Wo Y; Guo J; Li P; Yang H; Wo J
    Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
    Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
    J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.
    Li X; Wang H; Yao B; Xu W; Chen J; Zhou X
    Sci Rep; 2016 Oct; 6():36340. PubMed ID: 27796346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
    Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
    Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy.
    Lim TB; Aliwarga E; Luu TDA; Li YP; Ng SL; Annadoray L; Sian S; Ackers-Johnson MA; Foo RS
    Cardiovasc Res; 2019 Dec; 115(14):1998-2007. PubMed ID: 31114845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
    Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
    J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
    Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
    Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
    Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
    Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
    Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
    Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p.
    Chen Y; Liu X; Chen L; Chen W; Zhang Y; Chen J; Wu X; Zhao Y; Wu X; Sun G
    Biochem Biophys Res Commun; 2018 Nov; 505(3):807-815. PubMed ID: 30297107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ.
    He J; Jiang S; Li FL; Zhao XJ; Chu EF; Sun MN; Chen MZ; Li H
    J Investig Med; 2013 Mar; 61(3):604-12. PubMed ID: 23360843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
    Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
    Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy.
    Zhang Y; Zhang M; Xu W; Chen J; Zhou X
    Oncotarget; 2017 Apr; 8(17):28588-28594. PubMed ID: 28430627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.